Product Information

CARVEDILOL 25 MG TABLET is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $0.0321 per EA under NDC 82009012805. Its NADAC has been published 146 times since Nov 8, 2023.

FDA first approved this application on Sep 5, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CARVEDILOL 25 MG TABLET

Carvedilol
$0.0321per EA

Strength

25 mg/1

NDC

82009012805

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CARVEDILOL

Approval Type

Generic (ANDA)

FDA Application

ANDA077614

FDA Approved

9/5/2007

TE Code

AB

On Market Since

8/3/2023

Pharmacological Classes

Adrenergic alpha-Antagonists
Adrenergic beta1-Antagonists
Adrenergic beta2-Antagonists
alpha-Adrenergic Blocker
beta-Adrenergic Blocker

Price Statistics

The NADAC for CARVEDILOL 25 MG TABLET has been published 146 times since Nov 8, 2023, and over the history we have for it it has risen 2.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0321 per EA
All-time high$0.0323 (Aug 12, 2026)
All-time low$0.0255 (Nov 20, 2024)
52-week high$0.0323
52-week low$0.0311
Median price$0.0311
Average price$0.0306
Largest weekly change+18.4% (Aug 21, 2024)
Weeks tracked146
Tracking sinceNov 8, 2023

Price History

1W

-0.7%

1M

+0.4%

3M

+0.7%

6M

+1.6%

1Y

+4.9%

3Y

N/A

5Y

N/A

All

+2.5%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CARVEDILOL 25 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CARVEDILOL 25 MG TABLET, manufactured by Quallent Pharmaceuticals Health LLC, is $0.0321 per EA (NDC 82009012805), effective Aug 19, 2026.

How has the price of CARVEDILOL 25 MG TABLET changed over time?

Over the history we have for it, the NADAC for CARVEDILOL 25 MG TABLET has risen 2.5%. It has been tracked across 146 weekly CMS publications since Nov 8, 2023.

What are the highest and lowest recorded NADAC prices for CARVEDILOL 25 MG TABLET?

Since Nov 8, 2023, the NADAC for CARVEDILOL 25 MG TABLET has ranged from a low of $0.0255 (Nov 20, 2024) to a high of $0.0323 (Aug 12, 2026), with a median of $0.0311 per EA.

Are there cheaper alternatives to CARVEDILOL 25 MG TABLET?

Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CARVEDILOL 25 MG TABLET, is $0.0319 per EA — about 1% below CARVEDILOL 25 MG TABLET.

Who manufactures CARVEDILOL 25 MG TABLET?

CARVEDILOL 25 MG TABLET (NDC 82009012805) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.